Insulin requirements, basal-bolus distribution and basal patterns used by type 1 diabetic patients (T1DM) starting insulin pump therapy (CSII) and after glucose control optimisation

被引：0

作者：

Saigi, I. ^{[1
]}

Tundidor, D. ^{[1
]}

Jordana, L. ^{[1
]}

Maria, M. A. ^{[1
]}

Corcoy, R. ^{[1
]}

Chico, A. ^{[1
]}

机构：

[1] Hosp Santa Creu & Sant Pau, Eduab HSP, Barcelona, Spain

来源：

DIABETOLOGIA | 2010年 / 53卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1006

引用

页数：1

共 50 条

[21] Experience with Insulin-Bolus Calculator in Diabetes Type 1 Patients in Treatment on Basal-Bolus Regimen
Tejera, Cristina
Miguel Morales, Francisco
Maria Lopez, Ana
Galvan, Beatriz
Delgado, Esther
Beato, Pilar
Hernandez, Virginia
DIABETES, 2014, 63 : A596 - A596
[22] Transitioning T2DM Patients to Basal-Bolus Insulin Leads to Sustainable A1C Improvement
Barry, Romiya
Johns, Don
Rees, Buddug
DIABETES, 2019, 68
[23] Efficacy of Insulin Degludec as Basal-Bolus Therapy After Switching from Insulin Glargine or Insulin Detemir in Young Persons with Type 1 Diabetes
Urakami, Tatsuhiko
Habu, Masako
Okuno, Misako
Suzuki, Junichi
Takahashi, Shori
DIABETES, 2014, 63 : A323 - A323
[24] Stepwise Intensification of Prandial Insulin Versus Basal-Bolus Insulin Therapy in Patients (Pts) with Type 2 Diabetes Mellitus (T2DM)
Raccah, Denis
Haak, Thomas
Huet, Dominique
Monnier, Louis
Penfornis, Alfred
Robertson, Douglas
Labard, Pascale
Soler Ramon, Juan
DIABETES, 2010, 59 : A151 - A151
[25] Use of insulin degludec, a new basal insulin with an ultra-long duration of action, in basal-bolus therapy in type 1 and type 2 diabetes
Kerlan, Veronique
Gouet, Didier
Marre, Michel
Renard, Eric
ANNALES D ENDOCRINOLOGIE, 2013, 74 (5-6) : 487 - 490
[26] Introduction of insulin glargine to basal-bolus therapy improves metabolic control in patients with type 1 diabetes in everyday clinical practice
Donaubauer, B
Schneider, K
Schweitzer, MA
DIABETOLOGIA, 2005, 48 : A329 - A329
[27] Introduction of insulin glargine to basal-bolus therapy improves metabolic control in patients with type 1 diabetes in everyday clinical practice
Donaubauer, B
Schneider, K
Schweitzer, MA
DIABETES, 2005, 54 : A518 - A518
[28] Insulin Degludec: Reduction of Hypoglycemia during Basal-Bolus Therapy in Patients with Diabetes Mellitus Type 1 or 2
Luedemann, J.
Merker, L.
Milek, K.
Kaiser, M.
Wilhelm, B.
DIABETOLOGIE UND STOFFWECHSEL, 2013, 8 (01) : 35 - 42
[29] PP Infusion on Type 1 Diabetic Patients (T1DM) Reduces Insulin Requirements: A Pilot Study
Rabiee, A.
Thompson, M.
Andersen, D.
Elahi, D.
PANCREAS, 2009, 38 (08) : 1039 - 1039
[30] Switching from a human insulin basal-bolus regimen to insulin analog basal-bolus therapy with insulin detemir/insulin aspart improves glycemic control and reduces hypoglycemic episodes in patients with type 1 diabetes:: Results from German subgroup of the PREDICTIVE™ study
Maxeiner, Stephan
Hansen, Jes B.
Nauck, Michael
DIABETES, 2006, 55 : A127 - A127

← 1 2 3 4 5 →